Elona Kogan Esq.

General Counsel, ARIAD Pharmaceuticals.

Companies

Apimeds Pharmaceuticals US, Inc.Board member May 8, 2025 to now¹
Seer, IncGeneral counsel Dec 3, 2020 to Feb 23, 2024²
Selecta Biosciences (United States)General counsel Mar 27, 2019 to Jan 6, 2020³
ARIAD PharmaceuticalsGeneral counsel Jul 19, 2016 to Feb 16, 2017⁴

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Seer, Inc SEER273,142 shares⁵$554.5K at $2.03Feb 22, 2024

As of each latest filing. The line shows shares held over time.

Recent filings

Feb 22, 2024Sold 12,684 shares at $1.58 of Seer, Inc⁵
Feb 6, 2024Granted 123,153 shares of Seer, Inc⁵
Dec 4, 2023Sold 8,182 shares at $1.70 of Seer, Inc⁶
Feb 21, 2023Sold 5,951 shares at $4.13 of Seer, Inc⁷
Feb 15, 2023Granted 70,000 shares of Seer, Inc⁸
Jun 8, 2022Sold 8,185 shares at $8.91 of Seer, Inc⁹
Feb 8, 2022Granted 62,000 shares of Seer, Inc¹⁰

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARApimeds Pharmaceuticals US, Inc., Board member
2
SEC EDGARSeer, Inc, General counsel
3
SEC EDGARSelecta Biosciences (United States), General counsel
4
SEC EDGARARIAD Pharmaceuticals, General counsel
5
SEC EDGARSeer, Inc shares after the filing of Feb 22, 2024
6
SEC EDGARForm 4 filed Dec 6, 2023
7
SEC EDGARForm 4 filed Feb 22, 2023
8
SEC EDGARForm 4 filed Feb 17, 2023
9
SEC EDGARForm 4 filed Jun 10, 2022
10
SEC EDGARForm 4 filed Feb 10, 2022